BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.8% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DMRA
2326
Damora Therapeutics
DMRA
$1.46B
| $82.2M | ﹤0.01% |
3,162,068
+2,939,631
| +1,322% | +$71.2M |
2020 Q4
22 quarters
|
|
2327
Appian
APPN
$3.7B
| $82M | ﹤0.01% |
3,580,307
+354,220
| +11% | +$7.88M |
2017 Q2
36 quarters
|
|
2328
iShares Russell 1000 Value ETF
IWD
$82.7B
| $81.8M | ﹤0.01% |
337,493
-302,730
| -47% | -$70.5M |
2015 Q4
42 quarters
|
|
2329
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $81.7M | ﹤0.01% |
516,032
+367,215
| +247% | +$49.6M |
2020 Q2
24 quarters
|
|
2330
Brandywine Realty Trust
BDN
$551M
| $81.6M | ﹤0.01% |
25,755,775
+3,713,889
| +17% | +$11.2M |
2013 Q2
52 quarters
|
|
2331
Sun Life Financial
SLF
$39.8B
| $81.6M | ﹤0.01% |
1,040,385
+126,302
| +14% | +$9.09M |
2020 Q4
22 quarters
|
|
2332
Washington Trust Bancorp
WASH
$737M
| $81.6M | ﹤0.01% |
2,235,699
-220,170
| -9% | -$7.36M |
2013 Q2
52 quarters
|
|
2333
Lucid Motors
LCID
$1.3B
| $81.4M | ﹤0.01% |
12,174,275
+5,909,029
| +94% | +$38.1M |
2021 Q3
19 quarters
|
|
2334
Unusual Machines
UMAC
$616M
| $81.4M | ﹤0.01% |
3,648,657
+2,218,268
| +155% | +$41.1M |
2024 Q4
6 quarters
|
|
2335
iShares Staked Ethereum Trust ETF
ETHB
$620M
| $81.2M | ﹤0.01% |
4,000,000
| – | – |
2026 Q1
1 quarter
|
|
2336
Northrim BanCorp
NRIM
$523M
| $81.2M | ﹤0.01% |
2,926,599
+160,879
| +6% | +$3.99M |
2016 Q2
40 quarters
|
|
2337
X-Energy Inc
XE
$3B
| $80.8M | ﹤0.01% |
+4,399,867
| New | +$114M |
2026 Q2
0 quarters
|
|
2338
Avalo Therapeutics
AVTX
$372M
| $80.7M | ﹤0.01% |
4,365,553
+4,038,471
| +1,235% | +$63.8M |
2017 Q1
37 quarters
|
|
2339
Evolent Health
EVH
$518M
| $80.3M | ﹤0.01% |
14,814,851
+3,925,979
| +36% | +$15.1M |
2016 Q1
41 quarters
|
|
2340
CNA Financial
CNA
$12.8B
| $80.2M | ﹤0.01% |
1,649,720
-133,424
| -7% | -$6.07M |
2013 Q2
52 quarters
|
|
2341
BrightView Holdings
BV
$1.08B
| $80.1M | ﹤0.01% |
5,652,177
+437,052
| +8% | +$5.48M |
2018 Q2
32 quarters
|
|
2342
Diversified Energy Company
DEC
$877M
| $80M | ﹤0.01% |
5,774,418
+852,555
| +17% | +$12.9M |
2024 Q1
9 quarters
|
|
2343
Hyperliquid Strategies Inc
PURR
$1.74B
| $79.8M | ﹤0.01% |
10,145,166
+8,067,652
| +388% | +$59.7M |
2025 Q4
2 quarters
|
|
|
BZH
2344
DELISTED
Beazer Homes USA
BZH
| $79.8M | ﹤0.01% |
2,846,230
-36,581
| -1% | -$865K |
2013 Q2
52 quarters
|
|
2345
DELISTED
Northfield Bancorp
NFBK
| $79.6M | ﹤0.01% |
5,401,179
+174,183
| +3% | +$2.46M |
2013 Q2
52 quarters
|
|
2346
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$776M
| $79.5M | ﹤0.01% |
1,872,525
-116,481
| -6% | -$4.89M |
2015 Q3
43 quarters
|
|
2347
Symbotic
SYM
$4.78B
| $79M | ﹤0.01% |
1,756,855
+312,528
| +22% | +$15.9M |
2022 Q2
16 quarters
|
|
2348
Evolv Technologies
EVLV
$826M
| $78.5M | ﹤0.01% |
13,537,113
+2,000,590
| +17% | +$12.5M |
2021 Q3
19 quarters
|
|
2349
Castle Biosciences
CSTL
$993M
| $78.5M | ﹤0.01% |
3,291,963
+309,017
| +10% | +$6.88M |
2019 Q3
27 quarters
|
|
2350
Inhibrx
INBX
$1.24B
| $78.3M | ﹤0.01% |
825,972
+27,074
| +3% | +$2.71M |
2024 Q2
8 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 245 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 245 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.